Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Saint-Nicolas

5 clinical trials in Saint-Nicolas, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Saint-Nicolas at a glance
5
clinical trials
  • Recruiting now0
  • Not yet recruiting0
  • Research sites0
Type of trial
Recruitment status
Quick filters

5 trials in Saint-Nicolas

Open in trial search

Migraine+2

Not recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Atogepant
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Erenumab
  • Sponsor:Amgen Inc.
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Erenumab
  • Sponsor:Amgen Inc.

Migraine

Not recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Rimegepant
  • Sponsor:Pfizer Inc.

Other cities in Belgium

The busiest research cities in the country

All 170 cities in Belgium

Clinical research in Saint-Nicolas

What the registry says about research in the country

01 Migraine Research

Comprehensive studies focusing on acute migraine treatment and preventive therapies, evaluating novel medications for patients experiencing migraine attacks with or without aura.

  • Acute Treatment Evaluation
  • Preventive Therapy Assessment
  • Alternative Solutions for Triptan-Unsuitable Patients

Research aims to improve treatment options for those with inadequate response to conventional medications.

02 Treatment Efficacy Studies

Clinical investigations examining the effectiveness of new therapeutic agents for both single-attack treatment and long-term migraine prevention.

  • Pain Relief Assessment
  • Multiple Attack Management
  • Long-term Prevention Strategies

These trials evaluate both immediate relief and sustained preventive benefits for migraine sufferers.

03 Specialized Treatment Approaches

Research focusing on developing targeted therapies for patients who have shown insufficient response to standard migraine treatments.

  • Alternative Treatment Pathways
  • Medication Tolerance Studies
  • Patient-Specific Solutions

Studies aim to expand treatment options for diverse patient populations with varying migraine presentations.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.